1-5 of 5
Kris Attwood
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Germinal Center B-Cell-like (GCB) Phenotype Predicts Improved Outcomes in Central Nervous System Diffuse Large B-Cell Lymphoma Patients Receiving Stereotactic Radiosurgery (SRS)

Farhan Azad, Fatemeh Fekrmandi, Mody Amin, Victor Goulenko, Katy Wang, Kris Attwood, Dheerendra Prasad, Francisco J. Hernandez-Ilizaliturri
Journal: Blood
Blood (2023) 142 (Supplement 1): 6294.
https://doi.org/10.1182/blood-2023-181222
Published: 2023
Journal Articles

BCL-Xl Expression Is Druggable Biomarker Associated with a Poor Clinical Outcome in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Juan J. Gu, MD PhD, Michael Vacaro, Kris Attwood, PhD MS, Cory Mavis, MSc, Pallawi Torka, MD, Matthew J. Barth, MD, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1629.
https://doi.org/10.1182/blood-2019-128512
Published: 2019
Journal Articles

Outcomes of Follicular Lymphoma (FL) with Early Progression (EP): Does Choice of Second Line Therapy Impact the Course of Disease?

Ahmad Hanif, MD, Sumera Khan, MSc, MD, Pallawi Torka, MD, Kris Attwood, PhD MS, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4156.
https://doi.org/10.1182/blood-2018-99-117908
Published: 2018
Journal Articles

Outcomes of Patients with Limited-Stage Aggressive Large B-Cell Lymphoma with MYC Rearrangement with and without BCL2 and/or BCL6 Rearrangements: A Retrospective Analysis from 15 US Academic Centers

Shalin K. Kothari, MD, Shaoying Li, MD, L. Jeffrey Medeiros, MD, Emily C. Ayers, MD, Daniel J. Landsburg, MD, David A. Bond, MD, Kami J. Maddocks, MD, Anshu Giri, MD, Brian T. Hess, MD, Luu Q. Pham, Ranjana Advani, MD, Yang Liu, MD, Stefan Klaus Barta, MDMRCP,MS, Julie M. Vose, MDMBA, Michael C. Churnetski, BS, Jonathon B. Cohen, MDMS, Madelyn Burkart, MD, Reem Karmali, MD, Joanna Zurko, MD, Amitkumar Mehta, MD, Adam J Olszewski, MD, Sarah S Lee, MD, Brian T. Hill, MD PhD, Timothy F. Burns, MD, Frederick Lansigan, MD, Emma Rabinovich, MD, David Peace, MD, Adrienne Groman, MS, Kris Attwood, PhD MS, Francisco J. Hernandez-Ilizaliturri, MD, Pallawi Torka, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 451.
https://doi.org/10.1182/blood-2018-99-111530
Published: 2018
Journal Articles

Dose Reductions in Ibrutinib Therapy Are Not Associated with Inferior Outcomes in Patients with Chronic Lymphocytic Leukemia (CLL)

Othman S. Akhtar, MD, Kris Attwood, PhD MS, Ian Lund, PA-C, Ryan Hare, PharmD, Francisco J. Hernandez-Ilizaliturri, MD, Pallawi Torka, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5567.
https://doi.org/10.1182/blood-2018-99-112334
Published: 2018